Diagnostics

Test Detects and Monitors Peptic Ulcer and Gastric Cancer

Published in Cancer Weekly, September 5th, 2000

Biomerica, Inc. (BMRA), Newport Beach, California, introduced its Pepgen test as an aid to detect and monitor the presence of peptic ulcers and gastric carcinoma (stomach cancer).

The Pepgen test determines the quantity of Pepsinogen-1 present in human serum and can be used to measure the efficacy of treatment.

Peptic ulcers are developed by excessive secretion of pepsin/pepsinogen, caused by bacterial infection, anxiety, stress, alcohol, and also by using anti-inflammatory drugs. In U.S. alone, roughly 10% of the population develops peptic ulcers. Nearly 60% of the U.S. population over the age of 60, develops peptic and duodenal ulcers and they...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-09-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry